Bengaluru-based startup Ultrahuman has entered a two-year agreement with the Abu Dhabi Public Health Center to develop and clinically validate a biological age model that integrates wearable data and clinical biomarkers, with plans to offer the service across the United Arab Emirates.
- Two-year collaboration with Abu Dhabi Public Health Center to develop biological age model
- Model designed to work across various wearable devices and clinical data sources
- Service to be integrated into UAE government health platforms like TAMM and Sahatna
What happened
Ultrahuman, a health technology company known for its smart rings, has formalized a partnership with the Abu Dhabi Public Health Center to co-develop a biological age estimation model. This initiative involves a two-year memorandum of understanding focused on combining clinical biomarkers with data acquired from wearable devices.
The goal is to create and validate an algorithm that can estimate the rate at which individuals age by analyzing multiple health signals, such as sleep quality, cardiovascular metrics, metabolic indicators, and physical activity levels. This project aims to extend Ultrahuman's technology beyond its existing hardware products into a broader health analytics platform.
Why it matters
This partnership represents Ultrahuman’s first effort to deploy health algorithms at a national scale, potentially reaching a wider demographic than its current user base of around 800,000 smart ring customers worldwide. By working with government authorities, Ultrahuman can access population-level data without compromising privacy, as the model deployment will exclude personally identifiable information.
The biological age model's wearable-agnostic design allows integration with various devices beyond Ultrahuman's smart rings, including wristwatches and health patches, enhancing data inclusivity. This capability, combined with clinical data, could revolutionize preventive health management and personalized longevity tracking in the UAE.
What to watch next
Ultrahuman and Abu Dhabi Public Health Center will focus on research and clinical validation over the next two years, with phased plans for broad rollout through UAE government digital health platforms such as TAMM and Sahatna. The exact timeline for public availability has yet to be specified.
Meanwhile, the competitive landscape in Abu Dhabi’s health tech sector includes other wearable companies like Oura, which also collaborates with local health authorities on related preventive health initiatives. Monitoring how Ultrahuman's model differentiates itself and integrates with the UAE's expansive health data infrastructure will be critical for its success.